Oakworth Capital, Inc. Astrazeneca PLC Transaction History

Oakworth Capital, Inc.

$1.44 Billion
Q3 2024

A detailed history of Oakworth Capital, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Oakworth Capital, Inc. holds 9,079 shares of AZN stock, worth $595,854. This represents 0.05% of its overall portfolio holdings.

Number of Shares

9,079

Previous 9,399 3.4%

Holding current value

$595,854

Previous $733,000 3.55%

% of portfolio

0.05%

Previous 0.05%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$76.67 - $87.62 $24,534 - $28,038	-320 Reduced 3.4%	9,079 $707,000
Q4 2023 Jan 30, 2024	BUY	$61.89 - $69.28 $36,638 - $41,013	592 Added 6.72%	9,399 $633,000
Q3 2023 Oct 31, 2023	SELL	$64.85 - $71.7 $64 - $71	-1 Reduced 0.01%	8,807 $596,000
Q4 2022 Feb 03, 2023	BUY	$54.21 - $70.44 $3,903 - $5,071	72 Added 0.82%	8,808 $597,000
Q2 2022 Aug 05, 2022	SELL	$59.26 - $71.14 $105,127 - $126,202	-1,774 Reduced 16.88%	8,736 $577,000
Q1 2022 Apr 11, 2022	SELL	$55.72 - $67.12 $9,806 - $11,813	-176 Reduced 1.65%	10,510 $697,000
Q3 2021 Nov 10, 2021	BUY	$55.56 - $60.79 $557,933 - $610,453	10,042 Added 1559.32%	10,686 $642,000
Q1 2021 Apr 30, 2021	SELL	$47.16 - $54.44 $2,640 - $3,048	-56 Reduced 8.0%	644 $32,000
Q3 2019 Nov 13, 2019	SELL	$40.12 - $45.47 $10,591 - $12,004	-264 Reduced 27.39%	700 $31,000
Q2 2019 Aug 02, 2019	BUY	$37.28 - $41.68 $21,025 - $23,507	564 Added 141.0%	964 $40,000
Q3 2017 Nov 08, 2017	BUY	$28.96 - $34.0 $11,584 - $13,600	400	400 $12,000

Others Institutions Holding AZN

# of Institutions

1,359

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oakworth Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oakworth Capital, Inc. with notifications on news.

Account

Oakworth Capital, Inc. Astrazeneca PLC Transaction History